34.54
Schlusskurs vom Vortag:
$32.36
Offen:
$32.64
24-Stunden-Volumen:
2.48M
Relative Volume:
0.86
Marktkapitalisierung:
$5.24B
Einnahmen:
$3.24B
Nettoeinkommen (Verlust:
$304.90M
KGV:
16.61
EPS:
2.08
Netto-Cashflow:
$156.70M
1W Leistung:
+12.65%
1M Leistung:
-21.12%
6M Leistung:
-32.47%
1J Leistung:
-43.72%
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Vergleichen Sie BRKR mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BRKR
Bruker Corp
|
34.54 | 4.91B | 3.24B | 304.90M | 156.70M | 2.08 |
![]()
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.98B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.51B | 3.23B | 1.68 |
![]()
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 4.14B | 577.90M | 6.96 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
2024-12-19 | Eingeleitet | Guggenheim | Buy |
2024-12-10 | Eingeleitet | UBS | Neutral |
2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
2024-10-15 | Eingeleitet | Barclays | Overweight |
2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
2024-06-03 | Fortgesetzt | Jefferies | Buy |
2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
2022-10-21 | Eingeleitet | UBS | Buy |
2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
2021-10-15 | Fortgesetzt | Cowen | Market Perform |
2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2020-12-02 | Eingeleitet | Goldman | Sell |
2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
2020-01-07 | Eingeleitet | Citigroup | Buy |
2019-11-15 | Eingeleitet | Stifel | Hold |
2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
2019-06-24 | Bestätigt | Needham | Strong Buy |
2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
2019-05-06 | Bestätigt | Needham | Strong Buy |
2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
2019-05-03 | Hochstufung | UBS | Sell → Neutral |
2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
2019-02-12 | Bestätigt | BTIG Research | Buy |
2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Is Bruker Corporation stock risky to hold nowJuly 2025 PostEarnings & Comprehensive Market Scan Insights - thegnnews.com
Bruker Corp To Go Ex-Dividend On September 23rd, 2025 With 0.05 USD Dividend Per Share - 富途牛牛
Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know - Yahoo Finance
Bruker Maintains Quarterly Dividend of $0.05 per Share, Payable Oct. 3 to Holders of Record as of Sept. 23 - MarketScreener
Bruker to pay $0.05 quarterly dividend in October By Investing.com - Investing.com Canada
Bruker Announces Quarterly Dividend - Stock Titan
Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract - Yahoo Finance
Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors - The Globe and Mail
Why Investors Shouldn't Be Surprised By Bruker Corporation's (NASDAQ:BRKR) 31% Share Price Plunge - simplywall.st
Bruker Corporation (BRKR): A Bull Case Theory - MSN
` - Insider Monkey
Bruker Corp. (BRKR) Faces Funding Challenges, But Long-Term Fundamentals Remain Intact. - AInvest
Bruker Corp. (BRKR) Sheds 8.6% on Dismal Earnings, Outlook - MSN
Investors Don't See Light At End Of Bruker Corporation's (NASDAQ:BRKR) Tunnel And Push Stock Down 26% - 富途牛牛
Unlocking Bruker (BRKR) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
Bruker Corporation shares rise 1.11% premarket after securing multi-year contracts for explosives and chemical trace detection solutions. - AInvest
Earnings Miss: Bruker Corporation Missed EPS By 38% And Analysts Are Revising Their Forecasts - Yahoo Finance
Bruker Bets On Science, But Debt And Margins Weigh Heavy - Finimize
Beyond the Balance Sheet: What SWOT Reveals About Bruker Corp (B - GuruFocus
Bruker Corporation (NASDAQ:BRKR) Q2 2025 Earnings Call Transcript - Insider Monkey
Bruker Secures Contracts for Explosives, Chemical Trace Detection - MarketScreener
Bruker Corp secures multi-year contracts for trace detection - MarketScreener
BRUKER CORP SEC 10-Q Report - TradingView
Bruker's Strategic Cost-Saving Initiatives and Margin Expansion Justify Buy Rating Amid Market Challenges - AInvest
These Analysts Slash Their Forecasts On Bruker After Weaker-Than-Expected Q2 ResultsBruker (NASDAQ:BRKR) - Benzinga
Bruker stock price target lowered to $40 by TD Cowen on weak demand - Investing.com
J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $50 - 富途牛牛
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $38 to $60 - 富途牛牛
Stifel lowers Bruker stock price target to $40 on weak academic spending - Investing.com Canada
JPMorgan lowers Bruker stock price target to $50 from $60, maintains Overweight rating - Investing.com
JPMorgan lowers Bruker stock price target to $50 from $60, maintains Overweight rating By Investing.com - Investing.com South Africa
Bruker Stock: Caution Warranted Despite Bullish Analyst Calls - 富途牛牛
Bruker Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Bruker Corp (BRKR) Q2 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... - Yahoo Finance
Bruker: Q2 Earnings Snapshot - Norwalk Hour
Bruker Corp (BRKR) Q2 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... By GuruFocus - Investing.com Canada
Bruker Corp (BRKR) Q2 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic Cost Reductions - GuruFocus
Barclays lowers Bruker stock price target to $43 from $46, maintains Overweight rating By Investing.com - Investing.com South Africa
Barclays lowers Bruker stock price target to $43 from $46, maintains Overweight rating - Investing.com
Why Bruker (BRKR) Shares Are Trading Lower Today - Yahoo Finance
Bruker Shares Fall on 2Q Earnings Miss, Lowered FY Outlook - 富途牛牛
Bruker Shares Fall Amid Lower Q2 Adjusted Earnings, Revenue; 2025 Adjusted EPS, Revenue Guidance Cut - MarketScreener
Earnings call transcript: Bruker Q2 2025 misses forecasts, stock drops By Investing.com - Investing.com Canada
Earnings call transcript: Bruker Q2 2025 misses forecasts, stock drops - Investing.com
Bruker Q2 2025 Earnings Call Transcript - MarketBeat
Bruker Corporation stock hits 52-week low at 34.0 USD By Investing.com - Investing.com Canada
Bruker Corporation stock hits 52-week low at 34.0 USD - Investing.com
Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Bruker Misses Expectations And Lowers Its Outlook For The Year - Finimize
Bruker Corp. Sees Modest Q2 Profit with Revenue GrowthNews and Statistics - IndexBox
Bruker (BRKR) Misses Q2 Earnings Estimates - Yahoo Finance
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bruker Corp-Aktie (BRKR) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
ORNELL JOHN A | Director |
May 13 '25 |
Option Exercise |
18.15 |
5,000 |
90,750 |
31,445 |
LINTON WILLIAM A | Director |
Apr 22 '25 |
Option Exercise |
24.00 |
10,000 |
240,000 |
58,723 |
Bures Thomas | Chief Accounting Officer |
Mar 10 '25 |
Buy |
47.40 |
500 |
23,698 |
3,472 |
LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):